
    In re BUSPIRONE PATENT LITIGATION MULTIDISTRICT PATENT LITIGATION, Bristol-Myers Squibb Company, Plaintiff-Appellant, v. Mylan Pharmaceuticals, Inc., Mylan Laboratories Inc., and Mylan Technologies, Inc., Defendants-Appellees, and Danbury Pharmacal, Inc. and Watson Pharmaceuticals, Inc., Defendants-Appellees.
    No. 02-1374, 02-1375, 02-1376, 02-1377, 02-1378, 02-1379.
    United States Court of Appeals, Federal Circuit.
    March 17, 2003.
   ORDER

The parties having so agreed, it is

ORDERED that the proceeding is DISMISSED under Fed. R.App. P. 42(b).  